Purchase Order N6809420P6078
Award Date 10/1/20
Potential Completion Date 9/27/21
Potential Value $85K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Health Agency (operating under the Medical Supply Chain) awarded a fixed-price delivery order valued at $2,716.20 to Ortho-Clinical Diagnostics, Inc. for Anti-A Bioclone 150ML monoclonal antibody reagent with ABO blood group typing capabilities. This delivery order, issued December 5, 2025, with an ultimate completion date of March 2, 2026, represents a task order issued under the company's existing Indefinite Delivery Contract vehicle. The contract utilized open competition...
- Ortho-Clinical Diagnostics, Inc. was awarded a $1,953.50 delivery order by the Defense Health Agency's Medical Supply Chain on November 24, 2025, for Reagent Anti-D Bioclone 150ML in the ABO Group BB blood typing classification. The contract utilizes a firm fixed price structure with no set-aside designation and is scheduled for completion by November 25, 2025. Performance will occur at the contractor's Raritan, New Jersey facility, where Ortho-Clinical Diagnostics manufactures advanced...
- The Defense Health Agency, operating under the Defense Department's Medical Supply Chain, awarded a delivery order valued at $1,037.23 to Ortho-Clinical Diagnostics, Inc. on January 7, 2026, for Anti-D Bioclone 150ML monoclonal antibodies used in blood bank operations. The contract utilizes a firm fixed-price structure with a completion date of January 8, 2026, and was procured through open competition with no set-aside designation. Performance will occur at Ortho-Clinical Diagnostics'...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order valued at $2,074.46 by the Defense Health Agency's Medical Supply Chain on August 5, 2025, for the supply of Rh antigen anti-D blood bank reagent in 150ml monoclonal ABO group format. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Performance is scheduled for completion by August 8, 2025, at the contractor's facility in Raritan, New Jersey. This delivery order represents a...
- Ortho-Clinical Diagnostics, Inc. was awarded a $106,667.83 delivery order for automated blood grouping equipment and services by the Defense Health Agency on September 28, 2021, with a completion date of September 27, 2023. This firm fixed-price contract, which utilized no set-aside designation, represents a task order under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule. The work is to be performed at the contractor's facility in Raritan, New...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-A Bioclone 15x10ML on August 1, 2025, with an ultimate completion date of August 6, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Performance will occur at the contractor's facility in Raritan, New Jersey. Ortho-Clinical Diagnostics, Inc., a for-profit...
- The Defense Department's Medical Supply Chain has awarded a delivery order valued at $4.7K to Ortho-Clinical Diagnostics, Inc. for blood group serum, effective June 2, 2025, with an ultimate completion date of June 23, 2025. This fixed-price delivery order with economic price adjustment provisions will be performed at the contractor's facility in Raritan, New Jersey. The contract was awarded without set-aside designations, indicating open competition among qualified vendors. Ortho-Clinical...
- The Defense Health Agency awarded a purchase order valued at $106,717.41 to Ortho-Clinical Diagnostics, Inc. for ortho-clinical blood analyzer reagents and optical equipment, with a performance location at Fort Drum, New York. The contract, awarded on November 21, 2023, utilizes firm fixed price pricing and is structured as a standard purchase order with no set-aside designation. The ultimate completion date is November 20, 2028, providing a multi-year supply arrangement for critical...
- Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a delivery order valued at $4,581.35 by the Defense Medical Supply Chain on May 28, 2025, with completion expected by June 2, 2025. The contract covers the supply of Rh anti-B reagent in 150-milliliter quantities for blood bank analysis and ABO blood group testing. This firm fixed-price delivery order was issued without a set-aside designation, indicating open competition, and represents a continuation of the...
- Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a Blanket Purchase Agreement (BPA) call valued at $12,179.85 on December 3, 2025, for reagents for blood testing. The Defense Health Agency, under the Department of Defense, funded this award. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by September 30, 2026. This award represents a delivery order against an existing BPA vehicle, leveraging the General...